Benz, M. R., Sander, A., Ehren, R., Höcker, B., Fichtner, A., Gellermann, J., . . . Weber, L. T. (2026). Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): A multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial. The lancet child & adolescent health, 10(5), . https://doi.org/10.1016/S2352-4642(25)00373-6
Cita Chicago Style (17a ed.)Benz, Marcus R., et al. "Mycophenolate Mofetil Versus Prednisone for the Initial Treatment of Idiopathic Steroid-sensitive Nephrotic Syndrome in Children in Germany (INTENT): A Multicentre, Open-label, Randomised, Controlled, Parallel-group, Non-inferiority, Phase 3 Trial." The Lancet Child & Adolescent Health 10, no. 5 (2026). https://doi.org/10.1016/S2352-4642(25)00373-6.
Cita MLA (9a ed.)Benz, Marcus R., et al. "Mycophenolate Mofetil Versus Prednisone for the Initial Treatment of Idiopathic Steroid-sensitive Nephrotic Syndrome in Children in Germany (INTENT): A Multicentre, Open-label, Randomised, Controlled, Parallel-group, Non-inferiority, Phase 3 Trial." The Lancet Child & Adolescent Health, vol. 10, no. 5, 2026, https://doi.org/10.1016/S2352-4642(25)00373-6.